| | 
Investor Relations Home
News Releases
Events, Webcasts & Presentations
Corporate Governance
Stock Information
Annual Reports & SEC Filings
Analysts
Information Request
 | | 2010 News Releases |
|
| Date | Title | | | 02/02/10 | Facet Biotech to Present at 12th Annual Bio CEO & Investor Conference| REDWOOD CITY, CA, Feb 02, 2010 (MARKETWIRE via COMTEX) -- Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at the 2010 BIO CEO & Investor Conference in New York on Tuesday, February 9, 2010 at 8:30 a.m., Eastern Time. The conference is hosted by the Biotechnology Industry Organization (BIO) and will take place from February 8-9, 2010.
A live webcast of the presentation will be available through the Facet website at www.facetbiotech.com. Please conn... |
|  | | 01/11/10 | Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma| Company to Receive $15 Million Milestone Payment From Bristol-Myers Squibb
REDWOOD CITY, CA, Jan 11, 2010 (MARKETWIRE via COMTEX) -- Facet Biotech Corporation (NASDAQ: FACT) today announced enrollment of the first patient into the randomized phase 2 portion of the ongoing Phase 1/2 study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM) in combination with lenalidomide and low-dose dexamethasone. As a result, Facet Biotech wil... |
| |
|
| | |
